Navigation Links
Leading European Contract Research Organization Selects OmniComm to Provide eClinical Solutions for Important Phase III Study
Date:8/13/2009

anies that range from small, to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc has U.S. headquarters in Fort Lauderdale, FL and European headquarters in Bonn, Germany, with satellite offices in New Jersey, the United Kingdom, and Russia as well as sales offices throughout the U.S. and Europe.

Safe Harbor Disclaimer

Statements made by OmniComm included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

    CONTACT:   Stephen Johnson at: + 1 954-377-1726

               Catherine Lemercier
               OmniComm Systems, Inc
               954-473-1254 Extension 283
               clemercier@omnicomm.com

               Gary Nash
               CEOcast, Inc. for OmniComm
               212-732-4300
               gnash@ceocast.com


'/>"/>
SOURCE OmniComm Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading
2. Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services
3. One of the Nation's Leading Analytical Testing Laboratories is Now Easier to Access -- Pace Analytical Launches New Web Site to Showcase Its Three Business Divisions
4. OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor - Logos Technologies, Ltd.
5. Junying Yu, Leading Stem Cell Researcher, Joins Cellular Dynamics International
6. NeoStem, Inc. Appoints Leading Chinese Medical Official to Its Advisory Board
7. Finesse Solutions Forges Agreement With Leading Biotechnology Company for Single-Use Technology Exploration
8. Leading for Growth in the New Economic Reality Includes Vision and Innovation
9. National Institutes of Health Join Nations Leading Postgrad Bio Jobs Board
10. The World's Leading IP Strategists Revealed
11. PAREXEL Experts to Present Leading Insights at Drug Information Association 45th Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ING OF PRUSSIA, Pa., Nov. 30 Cadi...lizing in interactive marketing services and solu... the launch of its HATCH Consulting services...ning strategic experts across a range of emerging ...Consulting team is committed to guiding companies ...
(Date:11/30/2009)..., Nov. 30 The Michael J...oday announced $1.5 million in total awards to six...ease-modifying therapies for Parkinson,s disease. ...s to Drug Discovery for Parkinson,s Disease progr..., plc (NYSE: ELN ), a neuroscience-based biotech...
(Date:11/30/2009)...ARCLIFF MANOR, N.Y., Nov. 30 Good ...ment for the publication of company-sponsored medi...he British Medical Journal (BMJ). "The publication...tance of providing support and guidance for indust... results in the peer-reviewed medical literature,"...
(Date:11/30/2009)...ov. 30 Dr. Jessica Torrente, Assis...niversity Medical Center in Washington, D.C., demo...c Gamma Imaging (BSGI) in clinical practice as an ...st cancer today at the annual meeting of the Radio...e purpose of the exhibit was to demonstrate how BS...
Breaking Biology Technology:Cadient Interactive Announces the Launch of HATCH Consulting Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 3The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 2ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 3Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2
...MARKET HYPEROPIC ICL APPROVALS POSITION COMPAN...alif., Feb. 29 STAAR Surgical,Company (Nasdaq: S...ter of,minimally invasive ophthalmic products, tod...te Food and Drug Administration of the People,s,Re...TM) Toric Implantable,Collamer Lens to ophthalmolo...
...ind,Corporation (Nasdaq: MNKD ) will release its ...March 4, 2008 at 7:00 a.m. ET., Management of the...e,fourth quarter financial results, clinical progr... on Tuesday, March 4, 2008. Presenting from the,Co...icer, Alfred Mann;,President and Chief Operating O...
...swire/ -. Actavis Group, the,international generic...r,Irinotecan Hydrochloride Injection from the U.S....roduct will begin immediately., Irinotecan Hydroc...r,s,Camptosar(R) will be available in 40 mg/2 mL a... of patients with metastatic carcinoma of the colo...
Other Biology Technology:STAAR Surgical Receives Approval to Market Visian(R) Toric Implantable Collamer Lens in China 2STAAR Surgical Receives Approval to Market Visian(R) Toric Implantable Collamer Lens in China 3MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on March 4, 2008 2Actavis Receives Approval for Irinotecan Hydrochloride Injection; Extends US Portfolio with First Injectable Product 2
(Date:11/26/2009)...red deer have been caught in the hunters, sights f... than decorative. They are lethal weapons that sta... The University of York, UK, has been intrigued by... century and has become fascinated by the mechanic...llaboration with Tomas Landete-Castillejos at the ...
(Date:11/26/2009)... Whitehead researchers have developed a new type o...fic genes and proteins used by pathogens, accordin...ell cultures genes are present in two copies: one ... Gene inactivation by mutation is therefore ineffi...cond copy usually remains active and takes over. ,...
(Date:11/25/2009)...ifornia Institute of Technology (Caltech) have unc...or in the fruit fly, Drosophila melanogaster . ,...ationship between the neurotransmitter dopamine an... are described in the December issue of the journa...ly about 20,000 neurons and has long been consider...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Knockouts in human cells point to pathogenic targets 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Food Network Star Jeffrey Saad Teams Up with Omelet King Howard Helmer 59125 1Food Network Star Jeffrey Saad Teams Up with Omelet King Howard Helmer 59125 2Food Network Star Jeffrey Saad Teams Up with Omelet King Howard Helmer 59125 3Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796 Broad Spectrum Oral and IV Antibiotic in Phase 3 5318 1Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796 Broad Spectrum Oral and IV Antibiotic in Phase 3 5318 2Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796 Broad Spectrum Oral and IV Antibiotic in Phase 3 5318 3STEMCELL Technologies Inc Announces Direct Distribution to Spain 59120 1STEMCELL Technologies Inc Announces Direct Distribution to Spain 59120 2STEMCELL Technologies Inc Announces Direct Distribution to Spain 59120 3STEMCELL Technologies Inc Announces Direct Distribution to Spain 59120 4
... found in oceans could make the manufacture of pro...cs to credit card holograms, cheaper and greener. ...olved hundreds of millions of years ago, has a har..., the shell displays vivid colours that change dep...effect is caused by a complex network of tiny hole...
...tlantic airlines with liquid explosives was uncove...ure on the airline industry, and Homeland Security...aggage and on airline passengers, but also to figu...chnology Directorate (S&T) is teaming with scienti...a possible solution. , Having to place your consu...
...ompound that has already shown it can attack the r...nto human clinical trials, according to a new arti...e journal, Blood. , The Rochester team has been l... on the deadly blood cancer for nearly five years....ent studies in that time is very fast progress in ...
Other Biology News:Nature leads the way for the next generation of paints, cosmetics and holograms 2Menace in a bottle 2Daisies lead scientists down path to new leukemia drug 2
Mouse Anti-Human IFN-Gamma RC2 (CD118) Non-Neutralizing Monoclonal Antibody, Unconjugated, Clone MMHGR-2 from PBL InterferonSource
Rat CINC-2 alpha, Unconjugated from R&D Systems
Rat Anti-Mouse F4 / 80 Antigen Monoclonal Antibody, Biotin Conjugated from AbD Serotec
Sheep NP-SGG (Sheep Gamma Globulin), Unconjugated from Biosearch Technologies
Biology Products: